Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Neoadjuvant Dose-Dense Doxorubicin, Ifosfamide, and Irinotecan (CPT-11) for Advanced Soft Tissue and Recurrent Bone Sarcomas

NCT00544778 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00544778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00544778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Neoadjuvant Dose-Dense Doxorubicin, Ifosfamide, and Irinotecan (CPT-11) for Advanced Soft Tissue and Recurrent Bone Sarcomas
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2001
Completion date
Not reported
Enrollment
7 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma